Abstract
Neutrophils are involved in the pathogenesis of allergy. However, the contribution of the different functionally polarized neutrophils in allergy needs to be clarified. We sought to define the characteristics of interleukin (IL)-33-induced neutrophils and the involvement of this subset of polarized neutrophils in allergic pathogenesis. Freshly isolated neutrophils were treated with different cytokines and the cytokine expression levels were detected by real-time PCR. The gene expression profile of IL-33-induced neutrophils was determined by microarray assay. Adoptive transfer assay was used to investigate the function of IL-33-induced neutrophils in an ovalbumin (OVA)-induced allergic asthma model. IL-33-treated neutrophils selectively produced IL-4, IL-5, IL-9 and IL-13 (referred as to N(IL-33) cells) and displayed a distinctive gene expression profile in sharp contrast to resting and lipopolysaccharide (LPS)-treated neutrophils. IL-33-induced neutrophils expressed high Levels of IL-1R2 on cell surface, whereas resting and LPS-treated neutrophils did not, indicating IL-1R2 might be used as a biomarker for N(IL-33) cells. Importantly, N(IL-33) neutrophils exist in the lungs of OVA-induced allergic asthma mice. Adoptive transfer of N(IL-33) neutrophils significantly promotes the severity of the lung pathogenesis in this model. IL-33 induces neutrophil polarization through c-Jun N-terminal kinase- and nuclear factor-κB-dependent pathways. A previously unappreciated neutrophil polarization driven by IL-33 with unique cell surface markers and cytokine/chemokine-producing gene profile was defined. The newly identified N(IL-33) subpopulation may have significant contribution to IL-33-related pathogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fcmi.2017.163/MediaObjects/41423_2018_146_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fcmi.2017.163/MediaObjects/41423_2018_146_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fcmi.2017.163/MediaObjects/41423_2018_146_Fig3_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fcmi.2017.163/MediaObjects/41423_2018_146_Fig4_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fcmi.2017.163/MediaObjects/41423_2018_146_Fig5_HTML.jpg)
Similar content being viewed by others
References
Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 2013; 13: 159–175.
Xu R, Lin F, Bao C, Huang H, Ji C, Wang S et al. Complement 5a receptor-mediated neutrophil dysfunction is associated with a poor outcome in sepsis. Cell Mol Immunol 2016; 13: 103–109.
Nemeth T, Mocsai A. The role of neutrophils in autoimmune diseases. Immunol Lett 2012; 143: 9–19.
Wu T, Sun C, Chen Z, Zhen Y, Peng J, Qi Z et al. Smad3-deficient CD11b(+)Gr1(+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway. J Immunol 2012; 189: 4989–5000.
Colgan SP. Neutrophils and inflammatory resolution in the mucosa. Semin Immunol 2015; 27: 177–183.
Jaeger BN, Donadieu J, Cognet C, Bernat C, Ordonez-Rueda D, Barlogis V et al. Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis. J Exp Med 2012; 209: 565–580.
Chiewchengchol D, Midgley A, Sodsai P, Deekajorndech T, Hirankarn N, Beresford MW et al. The protective effect of GM-CSF on serum-induced neutrophil apoptosis in juvenile systemic lupus erythematosus patients. Clin Rheumatol 2015; 34: 85–91.
Cross A, Bucknall RC, Cassatella MA, Edwards SW, Moots RJ. Synovial fluid neutrophils transcribe and express class II major histocompatibility complex molecules in rheumatoid arthritis. Arthritis Rheum 2003; 48: 2796–2806.
Lakschevitz FS, Visser MB, Sun C, Glogauer M. Neutrophil transcriptional profile changes during transit from bone marrow to sites of inflammation. Cell Mol Immunol 2015; 12: 53–65.
Vitiello D, Neagoe PE, Sirois MG, White M. Effect of everolimus on the immunomodulation of the human neutrophil inflammatory response and activation. Cell Mol Immunol 2015; 12: 40–52.
Scapini P, Nardelli B, Nadali G, Calzetti F, Pizzolo G, Montecucco C et al. G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J Exp Med 2003; 197: 297–302.
Mhawech-Fauceglia P, Kaya G, Sauter G, McKee T, Donze O, Schwaller J et al. The source of APRIL up-regulation in human solid tumor lesions. J Leukoc Biol 2006; 80: 697–704.
Zindl CL, Lai JF, Lee YK, Maynard CL, Harbour SN, Ouyang W et al. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc Natl Acad Sci USA 2013; 110: 12768–12773.
Puga I, Cols M, Barra CM, He B, Cassis L, Gentile M et al. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol 2012; 13: 170–180.
Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: ‘N1’ versus ‘N2’ TAN. Cancer Cell 2009; 16: 183–194.
Li Y, Zhu L, Chu Z, Yang T, Sun HX, Yang F et al. Characterization and biological significance of IL-23-induced neutrophil polarization. Cell Mol Immunol 2017; e-pub ahead of print.
Molofsky AB, Savage AK, Locksley RM. Interleukin-33 in tissue homeostasis, injury, and inflammation. Immunity 2015; 42: 1005–1019.
Humphreys NE, Xu D, Hepworth MR, Liew FY, Grencis RK. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J Immunol 2008; 180: 2443–2449.
Kondo Y, Yoshimoto T, Yasuda K, Futatsugi-Yumikura S, Morimoto M, Hayashi N et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol 2008; 20: 791–800.
von Moltke J, Locksley RM. I-L-C-2 it: type 2 immunity and group 2 innate lymphoid cells in homeostasis. Curr Opin Immunol 2014; 31: 58–65.
Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010; 463: 540–544.
Sjoberg LC, Gregory JA, Dahlen SE, Nilsson GP, Adner M. Interleukin-33 exacerbates allergic bronchoconstriction in the mice via activation of mast cells. Allergy 2015; 70: 514–521.
Radermecker C, Sabatel C, Toussaint M, Johnston S, Bureau F, Marichal T. Release of neutrophils extracellular traps as a main trigger for asthma onset. Unpublished Conference/Abstract 2017 6th NIF Winter School on Advanced Immunology, January 22 to 26, Singapore, Singapore.
Foley SC, Hamid Q. Images in allergy and immunology: neutrophils in asthma. J Allergy Clin Immunol 2007; 119: 1282–1286.
Gao K, Li X, Zhang L, Bai L, Dong W, Gao K et al. Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice. Cancer Lett 2013; 335: 463–471.
Hou Y, Lin H, Zhu L, Liu Z, Hu F, Shi J et al. The inhibitory effect of IFN-gamma on protease HTRA1 expression in rheumatoid arthritis. J Immunol 2014; 193: 130–138.
Zhu L, Yang T, Li L, Sun L, Hou Y, Hu X et al. TSC1 controls macrophage polarization to prevent inflammatory disease. Nat Commun 2014; 5: 4696.
Hou Y, Lin H, Zhu L, Liu Z, Hu F, Shi J et al. Lipopolysaccharide increases the incidence of collagen-induced arthritis in mice through induction of protease HTRA-1 expression. Arthritis Rheum 2013; 65: 2835–2846.
Sun B, Hu X, Liu G, Ma B, Xu Y, Yang T et al. Phosphatase Wip1 negatively regulates neutrophil migration and inflammation. J Immunol 2014; 192: 1184–1195.
Liu G, Hu X, Sun B, Yang T, Shi J, Zhang L et al. Phosphatase Wip1 negatively regulates neutrophil development through p38 MAPK-STAT1. Blood 2013; 121: 519–529.
Tecchio C, Micheletti A, Cassatella MA. Neutrophil-derived cytokines: facts beyond expression. Front Immunol 2014; 5: 508.
Taylor PR, Roy S, Leal SM Jr., Sun Y, Howell SJ, Cobb BA et al. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2. Nat Immunol 2014; 15: 143–151.
Bryant VL, Slade CA. Chemokines, their receptors and human disease: the good, the bad and the itchy. Immunol Cell Biol 2015; 93: 364–371.
Lee YG, Jeong JJ, Nyenhuis S, Berdyshev E, Chung S, Ranjan R et al. Recruited alveolar macrophages, in response to airway epithelial-derived monocyte chemoattractant protein 1/CCl2, regulate airway inflammation and remodeling in allergic asthma. Am J Respir Cell Mol Biol 2015; 52: 772–784.
Andrade MV, Iwaki S, Ropert C, Gazzinelli RT, Cunha-Melo JR, Beaven MA. Amplification of cytokine production through synergistic activation of NFAT and AP-1 following stimulation of mast cells with antigen and IL-33. Eur J Immunol 2011; 41: 760–772.
Chang HC, Sehra S, Goswami R, Yao W, Yu Q, Stritesky GL et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 2010; 11: 527–534.
Perumal NB, Kaplan MH. Regulating Il9 transcription in T helper cells. Trends Immunol 2011; 32: 146–150.
Yang XO, Zhang H, Kim BS, Niu X, Peng J, Chen Y et al. The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation. Nat Immunol 2013; 14: 732–740.
Chung KF. Targeting the interleukin pathway in the treatment of asthma. Lancet 2015; 386: 1086–1096.
Abreu SC, Antunes MA, Mendonca L, Branco VC, de Melo EB, Olsen PC et al. Effects of bone marrow mononuclear cells from healthy or ovalbumin-induced lung inflammation donors on recipient allergic asthma mice. Stem Cell Res Ther 2014; 5: 108.
Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479–490.
Pichery M, Mirey E, Mercier P, Lefrancais E, Dujardin A, Ortega N et al. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol 2012; 188: 3488–3495.
Theoharides TC, Petra AI, Taracanova A, Panagiotidou S, Conti P. Targeting IL-33 in autoimmunity and inflammation. J Pharmacol Exp Ther 2015; 354: 24–31.
Savenije OE, Mahachie John JM, Granell R, Kerkhof M, Dijk FN, de Jongste JC et al. Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood. J Allergy Clin Immunol 2014; 134: 170–177.
Lee HY, Rhee CK, Kang JY, Byun JH, Choi JY, Kim SJ et al. Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma. Exp Lung Res 2014; 40: 66–76.
Morita H, Arae K, Unno H, Miyauchi K, Toyama S, Nambu A et al. An interleukin-33-mast cell-interleukin-2 axis suppresses papain-induced allergic inflammation by promoting regulatory T cell numbers. Immunity 2015; 43: 175–186.
Zhao P, Xiao X, Ghobrial RM, Li XC. IL-9 and Th9 cells: progress and challenges. Int Immunol 2013; 25: 547–551.
Forbes EE, Groschwitz K, Abonia JP, Brandt EB, Cohen E, Blanchard C et al. IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med 2008; 205: 897–913.
Traynor TR, Herring AC, Dorf ME, Kuziel WA, Toews GB, Huffnagle GB. Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity. J Immunol 2002; 168: 4659–4666.
Bruijnzeel PL, Uddin M, Koenderman L. Targeting neutrophilic inflammation in severe neutrophilic asthma: can we target the disease-relevant neutrophil phenotype? J Leukoc Biol 2015; 98: 549–556.
Makrinioti H, Toussaint M, Jackson DJ, Walton RP, Johnston SL. Role of interleukin 33 in respiratory allergy and asthma. Lancet Respir Med 2014; 2: 226–237.
O'Byrne PM, Metev H, Puu M, Richter K, Keen C, Uddin M et al. Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial. Lancet Respir Med 2016; 4: 797–806.
Dworski R, Simon HU, Hoskins A, Yousefi S. Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways. J Allergy Clin Immunol 2011; 127: 1260–1266.
Monteyne P, Renauld JC, Van Broeck J, Dunne DW, Brombacher F, Coutelier JP. IL-4-independent regulation of in vivo IL-9 expression. J Immunol 1997; 159: 2616–2623.
Gessner A, Blum H, Rollinghoff M. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Immunobiology 1993; 189: 419–435.
Acknowledgements
We thank Dr Lianjun Zhang and Dr Aqeel Javeed for their kind review of the manuscript. This work was supported by grants from the National Natural Science Foundation of China for General and Key Programs (81530049 and 81130055 to YZ), Knowledge Innovation Program of Chinese Academy of Sciences (XDA04020202-19 to YZ), the CAS/SAFEA International Partnership Program for Creative Research Teams (to YZ) and Beijing Municipal Hospital Authority ‘Yangfan Program’ (ZYLX201408 to XZ).
Author contributions
BS, LZ and YT designed and carried out the experiments, analyzed data and wrote the manuscript; H-XS analyzed microarray data; PW performed real-time PCR assays; YZ performed ELISA assays; YL performed animal models and flow cytometry; XZ and YH analyzed data and revised the manuscript; LZ, NN and YZ designed experiments, analyzed data, wrote the manuscript and provided overall supervision.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Sun, B., Zhu, L., Tao, Y. et al. Characterization and allergic role of IL-33-induced neutrophil polarization. Cell Mol Immunol 15, 782–793 (2018). https://doi.org/10.1038/cmi.2017.163
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2017.163
Keywords
This article is cited by
-
Wip1 inhibits neutrophil extracellular traps to promote abscess formation in mice by directly dephosphorylating Coronin-1a
Cellular & Molecular Immunology (2023)
-
Macrophage-intrinsic DUOX1 contributes to type 2 inflammation and mucus metaplasia during allergic airway disease
Mucosal Immunology (2022)
-
Spaceflight and simulated microgravity suppresses macrophage development via altered RAS/ERK/NFκB and metabolic pathways
Cellular & Molecular Immunology (2021)
-
The functional diversity of neutrophils and clustered polarization of immunity
Cellular & Molecular Immunology (2020)
-
Innate-like Lymphocytes and Innate Lymphoid Cells in Asthma
Clinical Reviews in Allergy & Immunology (2020)